Nasdaq
nasdaq.activitypub.awakari.com.ap.brid.gy
Nasdaq
@nasdaq.activitypub.awakari.com.ap.brid.gy
Interest: Nasdaq (details)

Awakari _interest_ is an automated account publishing a relevant only content.

Create your own interest in Awakari […]

[bridged from https://awakari.com/sub-details.html?id=Nasdaq on the fediverse by https://fed.brid.gy/ ]
Maxim Group Forecasts Strong Price Appreciation for Datavault AI (NASDAQ:DVLT) Stock Maxim Group increased their price objective on Datavault AI from $3.00 to $4.00 and gave the company a "buy&...

Origin | Interest | Match
Maxim Group Forecasts Strong Price Appreciation for Datavault AI (NASDAQ:DVLT) Stock
Maxim Group increased their price objective on Datavault AI from $3.00 to $4.00 and gave the company a "buy" rating in a research report on Monday.
www.marketbeat.com
January 5, 2026 at 6:57 PM
Weekly Investment Analysts’ Ratings Changes for Nektar Therapeutics (NKTR) Several brokerages have updated their recommendations and price targets on shares of Nektar Therapeutics (NASDAQ: NKTR) ...

#Analyst #Articles #- #Company #Sum #Banking

Origin | Interest | Match
Weekly Investment Analysts’ Ratings Changes for Nektar Therapeutics (NKTR)
Several brokerages have updated their recommendations and price targets on shares of Nektar Therapeutics (NASDAQ: NKTR) in the last few weeks: 12/29/2025 – Nektar Therapeutics had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings. 12/22/2025 – Nektar Therapeutics had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings. 12/17/2025 – Nektar Therapeutics […]
www.tickerreport.com
January 5, 2026 at 5:27 PM
CeriBell (NASDAQ:CBLL) Hits New 12-Month High - Here's Why CeriBell (NASDAQ:CBLL) Reaches New 52-Week High - Should You Buy?

Origin | Interest | Match
CeriBell (NASDAQ:CBLL) Hits New 12-Month High - Here's Why
CeriBell (NASDAQ:CBLL) Reaches New 52-Week High - Should You Buy?
www.marketbeat.com
January 5, 2026 at 5:09 PM
This $2 Billion Small Cap ETF Positions Investors Away From Stretched Tech Valuations After a decade of Big Tech dominance that delivered strong returns to Nasdaq investors, the market may be setti...

#Investing

Origin | Interest | Match
Awakari App
awakari.com
January 5, 2026 at 5:52 PM
www.investors.com
January 5, 2026 at 4:11 PM
January 5, 2026 at 4:51 PM
Cardiff Oncology (NASDAQ:CRDF) Now Covered by Noble Financial Investment analysts at Noble Financial started coverage on shares of Cardiff Oncology (NASDAQ:CRDF – Get Free Report) in a research n...

#Analyst #Articles #- #US #Banking

Origin | Interest | Match
Cardiff Oncology (NASDAQ:CRDF) Now Covered by Noble Financial
Investment analysts at Noble Financial started coverage on shares of Cardiff Oncology (NASDAQ:CRDF – Get Free Report) in a research note issued on Monday. The brokerage set an “outperform” rating and a $12.00 price target on the stock. Noble Financial’s price objective points to a potential upside of 346.93% from the stock’s previous close. Separately, […]
www.tickerreport.com
January 5, 2026 at 3:31 PM
Live Nasdaq Composite: Markets Advance Despite Rising Geopolitical Headwinds Live Updates Dow Reaches Record Territory 16 minutes ago Live The Dow Jones Industrial Average is soaring over 750 point...

#Investing #Market #News #Live #Earnings #Coverage #Live […]

[Original post on 247wallst.com]
Original post on 247wallst.com
247wallst.com
January 5, 2026 at 5:54 PM
Crude prices rise and oil company shares jump after the US raid on Venezuela NEW YORK (AP) — U.S. stocks are rising at the open led by technology and energy stocks. The S&P 500 rose 0.6% earl...

#US #& #World #video

Origin | Interest | Match
January 5, 2026 at 4:03 PM
vTv Therapeutics Inc. (NASDAQ:VTVT) Given Average Recommendation of "Moderate Buy" by Analysts Shares of vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) have been assigned an average ...

Origin | Interest | Match
vTv Therapeutics Inc. (NASDAQ:VTVT) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five analysts that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, three have given a buy reco
www.marketbeat.com
January 5, 2026 at 3:20 PM
Awakari App
awakari.com
January 5, 2026 at 4:04 PM
Retail traders push deeper into US equities, and benefit from gold and silver’s climb amid Venezuela tensions Capital.com’s latest client sentiment data points to a clear rotation underway:...

#Brokers #Commentary #Commentary #Equities #Latest #Latest #DIY […]

[Original post on diyinvestor.net]
Original post on diyinvestor.net
www.diyinvestor.net
January 5, 2026 at 6:16 PM
Comcast spinoff Versant starts trading on Nasdaq in rare media debut Versant, Comcast's spinoff of the majority of NBCUniversal's cable TV networks like MS Now and CNBC, started trading Mon...

Origin | Interest | Match
Comcast spinoff Versant starts trading on Nasdaq in rare media debut
Versant, Comcast's spinoff of the majority of NBCUniversal's cable TV networks like MS Now and CNBC, started trading Monday.
www.cnbc.com
January 5, 2026 at 2:40 PM
Tesla vs Nasdaq: Same Direction, Different Regimes At first glance, Tesla and the Nasdaq often appear to move in the same direction. Both benefit from risk-on environments, growth… Continue readi...

#data-science #machine-learning #artificial-intelligence

Origin | Interest | Match
Awakari App
awakari.com
January 5, 2026 at 2:40 PM
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (N...

#GlobeNewswire #GNW

Origin | Interest | Match
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash
NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature…
financialpost.com
January 5, 2026 at 3:28 PM
Up 85%: Should You Buy This Fintech Stock? Stocks have had a wild ride in 2025. While it wasn’t a smooth year, the stock market remained resilient despite the ups and downs. With the onset of the...

#Investing

Origin | Interest | Match
Awakari App
awakari.com
January 5, 2026 at 2:28 PM
Treasure Global regains Nasdaq compliance

#tgl #a

Origin | Interest | Match
Treasure Global regains Nasdaq compliance (TGL:NASDAQ)
Treasure Global (TGL) regains Nasdaq $1 bid price compliance; hearing canceled and shares stay listed.
seekingalpha.com
January 5, 2026 at 2:22 PM
www.investors.com
January 5, 2026 at 2:40 PM
2025 Cybersecurity Person Of The Year: Nir Zuk, Palo Alto Networks Founder & CTO This week in cybersecurity from the editors at Cybercrime Magazine Sausalito, Calif. – Jan. 5, 2026 –Read th...

#Blogs

Origin | Interest | Match
cybersecurityventures.com
January 5, 2026 at 4:15 PM
Kercheville Advisors LLC Raises Stock Holdings in Palantir Technologies Inc. $PLTR Kercheville Advisors LLC raised its position in shares of Palantir Technologies Inc. (NASDAQ:PLTR – Free Report)...

#Banking #SEC #Filing #Articles

Origin | Interest | Match
Kercheville Advisors LLC Raises Stock Holdings in Palantir Technologies Inc. $PLTR
Kercheville Advisors LLC raised its position in shares of Palantir Technologies Inc. (NASDAQ:PLTR – Free Report) by 19.0% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 28,065 shares of the company’s stock after purchasing an additional 4,475 shares during the period. Palantir Technologies comprises about 1.5% of Kercheville Advisors LLC’s investment portfolio, making […]
www.tickerreport.com
January 5, 2026 at 2:05 PM